Feb, 16 2024

促進呼吸健康：探索 α-1 抗胰蛋白酶缺乏症 (AATD) 增強療法以改善患者預後

Alpha-1 抗胰蛋白酶缺乏症 (AATD) 增強療法是一種醫療幹預措施，旨在解決身體產生不足的 Alpha-1 抗胰蛋白酶 (AAT) 蛋白質的遺傳狀況。 AAT 保護肺部免受酵素造成的損害。增強療法包括將純化的 AAT 注入血液以恢復足夠的水平。透過提高 AAT 水平，該療法旨在減緩 AATD 患者肺部疾病的進展，最終改善呼吸功能和整體生活品質。

訪問完整報告 @ https://www.databridgemarketresearch.com/reports/us-alpha-1-antitrypsin-deficiency-aatd-augmentation-therapy-market

Data Bridge Market Research 分析稱，美國 Alpha-1 抗胰蛋白酶缺乏症 (AATD) 增強療法市場規模在 2021 年為 5.6324 億美元，預計到 2029 年將達到 10.5203 億美元，預計在 2022-2029 年預測期內複合增長率為 9.0%。政府對 AATD 增強療法等罕見疾病治療的措施、補貼和支持對市場成長產生了積極影響，促進了有需要的患者獲得治療並負擔得起治療。

研究的主要發現

預計呼吸系統疾病的不斷升級將推動市場成長率

全球呼吸系統疾病盛行率不斷上升，尤其是與 α-1 抗胰蛋白酶缺乏症 (AATD) 相關的疾病，例如慢性阻塞性肺病(COPD)，加劇了對有效治療的需求。增強療法對於解決呼吸系統疾病發病率上升的問題至關重要，並強調了採用先進的治療幹預措施來減輕 AATD 對肺部健康的影響的必要性。這一趨勢推動了 AATD 增強療法市場的發展，使其成為全球呼吸系統疾病治療的關鍵組成部分。

報告範圍和市場細分

報告指標

細節

預測期

2022年至2029年

基準年

2021

歷史歲月

2020（可自訂為2014-2019）

定量單位

收入（百萬美元）、銷售（單位）、定價（美元）

涵蓋的領域

藥物（Prolastin、Aralast NP、Zemaira/Respreeza、Glassia 等）、基因類型（Pimz 型、Pims 型、Pizz 型等）、應用（肺病和肝病）、人群類型（成人和兒科）、最終用戶（醫院、專科診所、家庭醫療保健等）、分銷渠道（醫院藥房、零售藥房、網上藥房等）

涵蓋的市場參與者

Grifols, SA（西班牙）、CSL（澳洲）、Kamada Pharmaceuticals（以色列）、武田藥品工業株式會社（日本）、LFB BIOMEDICAMENTS（法國）、Arrowhead Pharmaceuticals, Inc.（美國）、Mereo Bioarma 集團 plc（英國）、Inhibrx,Factoressa.（美國）、Curp. Inc.（美國）、Apic Bio（美國）、Krystal Biotech（美國）、Beam Therapeutics（美國）、LOGICBIO THERAPEUTICS, INC.（美國）等

報告涵蓋的數據點

除了對市場價值、成長率、細分、地理覆蓋範圍和主要參與者等市場情景的洞察之外，Data Bridge Market Research 策劃的市場報告還包括深度專家分析、患者流行病學、管道分析、定價分析和監管框架。

細分分析：

美國 α-1 抗胰蛋白酶缺乏症 (AATD) 增強療法市場細分為藥物、基因類型、應用、人群類型、最終用戶和分銷管道。

根據藥物類型，美國 α-1 抗胰蛋白酶缺乏症 (AATD) 增強治療市場細分為 Prolastin、Aralast NP、Zemaira/Respreeza、Glassia 等

根據基因類型，美國 α-1 抗胰蛋白酶缺乏症 (AATD) 增強治療市場細分為 PiMZ 型、PiMS 型、PiZZ 型和其他

根據應用，美國 α-1 抗胰蛋白酶缺乏症 (AATD) 增強療法市場細分為肺部疾病和肝病

根據人口類型，美國 α-1 抗胰蛋白酶缺乏症 (AATD) 增強治療市場分為成人和兒童

根據最終用戶，美國 α-1 抗胰蛋白酶缺乏症 (AATD) 增強治療市場細分為醫院、專科診所、家庭醫療保健和其他

根據分銷管道，美國 α-1 抗胰蛋白酶缺乏症 (AATD) 增強療法市場細分為醫院藥房、零售藥房、線上藥房和其他

主要參與者

Data Bridge Market Research 認為以下公司是美國 α-1 抗胰蛋白酶缺乏症 (AATD) 增強療法市場的主要參與者，美國 α-1 抗胰蛋白酶缺乏症 (AATD) 增強療法市場的主要參與者包括 Grifols, SA（西班牙）、CSL（澳大利亞）、Kamada Pharmaceuticals（以色列）、武田藥品Inc.（美國）

市場發展

2023 年 5 月，Biogen 與歐洲一家著名的生物製藥公司合作，共同開創了一種新型 AATD 增強療法。該策略聯盟利用雙方的綜合生物技術實力來推進 α-1 抗胰蛋白酶缺乏症的治療方案，旨在滿足尚未滿足的醫療需求。此次合作彰顯了雙方對創新的共同承諾，可望擴大雙方合作治療努力的市場影響力

2023 年 3 月，Biogen 和阿斯特捷利康宣布達成策略合作，共同開創突破性的 α-1 抗胰蛋白酶缺乏症 (AATD) 增強療法。此次合作將整合雙方的專業知識和資源，推動 AATD 治療領域的進步，開啟滿足受影響個體需求的新時代。此次合作標誌著雙方共同努力，為 AATD 患者創新和改善治療方案

2021 年 6 月，著名生物製藥公司 Kamada Ltd. 宣布與武田藥品工業株式會社達成策略合作，率先推出針對 α-1 抗胰蛋白酶缺乏症的血漿衍生療法。此次合作將武田的專業知識與鐮田的先進技術相結合，旨在徹底改變 AATD 治療，提高患者的治療效果。此次合作彰顯了雙方對推動治療解決方案和促進市場擴張的共同承諾

2020 年 10 月，武田藥品工業株式會社揭露了與 Arrowhead Pharmaceuticals Inc. 達成的策略合作與授權協議。此次合作的重點是推進 ARO-AAT，這是一種用於治療 α-1 抗胰蛋白酶相關肝病 (AATLD) 的 2 期研發中的試驗性 RNA 幹擾 (RNAi) 療法。此次合作增強了武田的全球影響力，展現了透過創新治療方案應對 AATLD 的共同努力

有關美國 alpha-1 抗胰蛋白酶缺乏症 (AATD) 增強療法市場報告的更多詳細信息，請點擊此處 - https://www.databridgemarketresearch.com/reports/us-alpha-1-antitrypsin-deficiency-aatd-augmentation-therapy-market

CHOOSE LICENCE TYPE

Enterprise User 7000
Single User 4800
DBMR Factbook 3000
DBMR Prime 8000
DBMR Nucleus 12000

Buy Now

Advance Formative Research Customization Request for bulk Reports

Latest Press Release

Competitive Labor Costs and a Large Workforce Support High-Volume Apparel Production

Expanding FPC Adoption in Automotive and Medical Electronics is Expected to Drive the Market

Rising Prevalence of Chronic Diseases is the Driving Factor in the Market

Growing Focus on Nuclear Fusion Research Drives Soft Magnetic Material Demand

Growing Demand for Packaged Beverages, Pharmaceuticals, and Personal Care Products

Rising Demand for Packaged and Convenience Food Products, Supported by Rapid Urbanization and Lifestyle Changes, is Driving the Growth of the Global Flexible Packaging Market

VIEW ALL

Client Testimonials

Claudio Rondena

Group Business Development & Strategic Marketing Director,
C.O.C Farmaceutici SRL

"This morning we were involved in the first part, the data presentation of MKT analysis, selected abstract from your work. The board team was really impressed and very appreciated, as well."

David Manning - Thermo Fisher Scientific

Director, Global Strategic Accounts,

Dear Ricky,
I want to thank you for the excellent market analysis (LIMS INSTALLED BASE DATA) that you and your team delivered, especially end of year on short notice. Sachin and Shraddha captured the requirements, determined their path forward and executed quickly.
You, Sachin and Shraddha have been a pleasure to work with – very responsive, professional and thorough. Your work is much appreciated.

Manager - Market Analytics,

Uriah D. Avila - Zeus Polymer Solutions

Thank you for all the assistance and the level of detail in the market report. We are very pleased with the results and the customization. We would like to continue to do business.

Business Development Manager,

(Pharmaceuticals Partner for Nasal Sprays) | Renaissance Lakewood LLC

DBMR was attentive and engaged while discussing the Global Nasal Spray Market. They understood what we were looking for and was able to provide some examples from the report as requested. DBMR Service team has been responsive as needed. Depending on what my colleagues were looking for, I will recommend your services and would be happy to stay connected in case we can utilize your research in the future.

Business Intelligence and Analytics,

Ipsen Biopharm Limited

We are impressed by the CENTRAL PRECOCIOUS PUBERTY (CPP) TREATMENT report - so a BIG thanks to you colleagues.

Competition Analyst,

Basler Web

I just wanted to share a quick note and let you know that you guys did a really good job. I’m glad I decided to work with you. I shall continue being associated with your company as long as we have market intelligence needs.

Marketing Director,

Buhler Group

It was indeed a good experience, would definitely recommend and come back for future prospects.

COO,

A global leader providing Drug Delivery Services

DBMR did an outstanding job on the Global Drug Delivery project, We were extremely impressed by the simple but comprehensive presentation of the study and the quality of work done. This report really helped us to access untapped opportunities across the globe.

Marketing Director,

Philips Healthcare

The study was customized to our targets and needs with well-defined milestones. We were impressed by the in-depth customization and inclusion of not only major but also minor players across the globe. The DBMR Market position grid helped us to analyze the market in different dimension which was very helpful for the team to get into the minute details.

Product manager,

Fujifilms

Thankful to the team for the amazing coordination, and helping me at the last moment with my presentation. It was indeed a comprehensive report that gave us revenue impacting solution enabling us to plan the right move.

Investor relations,

GE Healthcare

Thank you for the report, and addressing our needs in such short time. DBMR has outdone themselves in this project with such short timeframe.

Market Analyst,

Medincell

We found the results of this study compelling and will help our organization validate a market we are considering to enter. Thank you for a job well done.

Andrew - Senior Global Marketing Manager,

Medtronic (US)

I want to thank you for your help with this report – It’s been very helpful in our business planning and it well organized.

Amarildo - Manager, Global Strategic Alignment

MasterCard

We believe the work done by Data Bridge Team for our requirements in the North America Loyalty Management Market was fantastic and would love to continue working with your team moving forward.

Tor Hammer

Green Nexus LLc

Thank you for your quick response to this unfortunate circumstance. Please extend my thanks to your reach team. I will be contacting you in the future with further projects

Tommaso Finocchiaro

Market Intelligence Specialist Nippon Gasses

I acknowledge the difficulty given by the very short warning for this report, and I think that its quality and your delivering time have been very satisfying. Obviously, as a provider Data Bridge Market Research will be considered as a plus for future needs of Nippon Gases.

Yuki Kopyl (Asian Business Development Department)

UENO FOOD TECHNO INDUSTRY, LTD. (JAPAN)

Xylose report was very useful for our team. Thank you very much & hope to work with you again in the future